Ns Pharma, Inc.
Clinical trials sponsored by Ns Pharma, Inc., explained in plain language.
-
New drug aims to tame rare autoimmune disease
Disease control Recruiting nowThis study is testing whether an investigational drug called NS-229 can help control a rare autoimmune disease called EGPA. It will compare NS-229 to a placebo in 45 adults who are already taking steroid medication. The main goal is to see if patients can achieve disease remissio…
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for boys with DMD: weekly infusion aims to restore muscle protein
Disease control Recruiting nowThis study is testing a new drug called NS-089/NCNP-02 for boys with Duchenne muscular dystrophy (DMD) caused by a specific genetic error (exon 44). The drug is given as a weekly IV infusion and aims to help muscles produce more of a crucial protein called dystrophin. Researchers…
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for boys with DMD: first human trial of potential Muscle-Saving drug begins
Disease control Recruiting nowThis is the first study in humans of a new drug called NS-050/NCNP-03 for boys with Duchenne muscular dystrophy (DMD). The main goals are to check if the weekly injections are safe and to see how the drug moves through the body. Researchers will also measure if the treatment help…
Phase: PHASE1, PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC